Latest Conference Articles

There has never been a randomized, controlled study that compared natalizumab and fingolimod for relapsing-remitting multiple sclerosis (RRMS) – until now at ECTRIMS 2016 in London, England.

Having been recently approved for patients with the relapsing form of multiple sclerosis more data is being done to show ways it can help manage symptoms while also being a safe option.

In a study led by Jérôme de Seze, MD, PhD, from the University Hospital of Strasbourg in France, researchers aimed to uncover more information on the medication, ocrelizumab, in patients with primary progressive multiple sclerosis (PPMS).

Recent findings have shown that vitamin D supplements improve multiple sclerosis (MS) relapse rates, however, a new study questions when those levels come into play.

“Although the etiology of multiple sclerosis (MS) remains elusive, it is clear that Epstein Barr Virus (EBV) and possibly other viruses have a role in the pathogenesis of MS,” researchers started a presentation at ECTRIMS 2016 in London, England.

Studies tend to yield better results than those found in a real-world setting. So to find “real” clinical outcomes with teriflunomide in patients with multiple sclerosis (MS), researchers conducted a phase 4 trial.

Delayed-release dimethyl fumarate (DMF) has yielded positive results in multiple sclerosis (MS) studies, however, the data has been limited to a particular population.

"The is no one living with HIV in this country who shouldn't have access to a treatment combination that works for them."

From showgirls to scientists, attendees at the 20th Annual US Conference on AIDS found much to celebrate and a lot left to be done in the quest to conquer HIV/AIDS.

According to Charles King, President and CEO of Housing Works, "It really doesn't matter what part of the world you're in. If you're having to struggle with issues around sexism, racism, homophobia, transphobia, homelessness, addiction, mental illness, they are all drivers of very bad health outcomes for people - whether you're talking about HIV, hepatitis C, or tuberculosis."

The treatment of multiple sclerosis has come a long way in recent years. However, there is a lot more to be done. There is optimism that over time treatment can be even more effective and help even more patients as new treatment methods are developed.

David Ho, MD, has been a pioneer in the development of AIDS antivirals, starting with his work on protease inhibitors 20 years ago. Kicking off the US Conference on AIDS today in Hollywood, FL, Ho said a new bi-monthly injection is looking like the next breakthrough in HIV/AIDS prevention.

Patients diagnosed with relapsing remitting multiple sclerosis have seen their treatment options increase dramatically in recent years. Now patients with the progressive forms are seeing the the start of momentum building in their favor.

Multiple sclerosis in itself has not shown to increase spontaneous abortions, stillbirth, cesarean delivery, premature birth, or birth defects – but what about the treatments?

Ravi Prasad, Phd, Stanford University, shared his work with the Stanford Comprehensive Interdisciplinary Pain Program to help improve patient quality of life.

A phase 3 study presented at PAINWeek 2016 in Las Vegas, Nevada, showed the benefits of using an electronic tracking system.

Whether it’s drugs or procedures, there are different strategies for managing chronic pain. However, when psychological symptoms come into play, treatment may need to take an alternative course.

In a perfect world, the pain data provided by diagnostic tests would match up with how a patient is actually feeling. However, the association is probably not as strong as doctors would like.

Researchers behind the potential new opioid, cebranopadol, presented efficacy and safety results at PAINWeek 2016 in Las Vegas, Nevada.

Pain management is everyone's job. It's a human problem.

Oxycodone is one opioid option for patients with chronic pain and other conditions. The drug, however, has not been extensively studied in older patients.

"Opiates are not the first line for every condition; they should not be reflexively prescribed," said Alexis LaPietra, DO, St. Joseph's Medical Center.

Different types of pain respond to different medications; so a collaborative team across the United States and United Kingdom looked at how the Chronic Pain Questionnaire (CPQ) can assist in making those important treatment decisions.

There’s many benefits to using nitrous oxide for analgesia – which is why it’s a staple for dentists. Dubbed “laughing gas,” the tasteless, colorless gas has proven to be safe and effective for both adults and children.

There is a lot of regulatory scrutiny, media attention, and confusion about managing pain, so patient education should be at the forefront of physicians' minds.

It may seem like opioids could be a “quick fix” for acute low back pain, but introducing the drugs early on increases the risk for dependency and addiction.

Pain is the single most common reason people seek medical attention - more than heart disease, diabetes, and hypertension.

When a patient presents at the emergency room with severe pain, there are various things to take into consideration before deciding on a course of action. But there are new options out there that probably aren’t at the forefront of your thinking.

Presented at PAINWeek 2016 in Las Vegas, Nevada, researchers looked at how turmeric could be used as a safer, more tolerable option for pain control.

In March 2016, the Centers for Disease Control and Prevention (CDC) published new guidelines for prescribing opioids. And while the aim is to curb the deadly opioid epidemic, some physicians saying that the changes could cause other prescription issues.